ciprofloxacin has been researched along with Spinal Cord Injuries in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Spinal Cord Injuries: Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral treatment with ciprofloxacin is an alternative to parenteral antibiotics in SCL-patients with urinary tract infection caused by resistant bacteria." | 5.28 | Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria. ( Biering-Sørensen, F; Høiby, N; Hørbov, S; Pedersen, SS, 1990) |
| "To evaluate the efficacy of low-dose long-term treatment with ciprofloxacin in the prevention of recurrent urinary tract infections in patients with spinal cord lesions and neurogenic bladder dysfunction, a prospective, randomized, cross-over, placebo-controlled study was performed." | 5.07 | Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. ( Biering-Sørensen, F; Bruun, B; Høiby, N; Nordenbo, A; Rahm, V; Ravnborg, M, 1994) |
| "A study was performed in 25 men with spinal cord injuries undergoing intermittent catheterization whose urine had > or = 10(5) bacterial colonies/ml to determine efficacy of ciprofloxacin in eradicating susceptible organisms from urine, urethra, and perineum." | 3.70 | Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury. ( Brookings, ES; Canupp, KC; DeVivo, MJ; Waites, KB, 1999) |
| "Oral treatment with ciprofloxacin is an alternative to parenteral antibiotics in SCL-patients with urinary tract infection caused by resistant bacteria." | 1.28 | Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria. ( Biering-Sørensen, F; Høiby, N; Hørbov, S; Pedersen, SS, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruijuan, Z | 1 |
| Li, X | 1 |
| Yingjie, W | 1 |
| Rui, W | 1 |
| Chunqing, L | 1 |
| Slim, E | 1 |
| Smit, CA | 1 |
| Bos, AJ | 1 |
| Peerbooms, PG | 1 |
| Dow, G | 1 |
| Rao, P | 1 |
| Harding, G | 1 |
| Brunka, J | 1 |
| Kennedy, J | 1 |
| Alfa, M | 1 |
| Nicolle, LE | 1 |
| Darouiche, RO | 1 |
| Smith, MS | 1 |
| Markowski, J | 1 |
| Foote, JE | 1 |
| Bennett, JK | 1 |
| Cowles, RS | 1 |
| Green, BG | 1 |
| Killorin, W | 1 |
| Biering-Sørensen, F | 2 |
| Høiby, N | 2 |
| Nordenbo, A | 1 |
| Ravnborg, M | 1 |
| Bruun, B | 1 |
| Rahm, V | 1 |
| Gimber, EA | 1 |
| Shields, MD | 1 |
| Canawati, HN | 1 |
| Sapico, FL | 1 |
| Krishnaswamy, A | 1 |
| El-Farra, R | 1 |
| Maeder, KN | 1 |
| Montgomerie, JZ | 1 |
| Waites, KB | 1 |
| Canupp, KC | 1 |
| Brookings, ES | 1 |
| DeVivo, MJ | 1 |
| Hurley, JC | 1 |
| Louis, WJ | 1 |
| Tosolini, FA | 1 |
| Carlin, JB | 1 |
| Pedersen, SS | 1 |
| Hørbov, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections (CARCUTI)[NCT02650518] | Phase 2/Phase 3 | 500 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for ciprofloxacin and Spinal Cord Injuries
| Article | Year |
|---|---|
Effects of Catheter Tracking Management on Urinary Tract Function and Infection Rates in Patients With Spinal Cord Injury.
Topics: Anti-Bacterial Agents; Catheters; Ciprofloxacin; Gentamicins; Humans; Levofloxacin; Piperacillin; Qu | 2023 |
A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Topics: Acute Disease; Adult; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterobacter | 2004 |
Antibiotic prophylaxis for urodynamic testing in patients with spinal cord injury: a preliminary study.
Topics: Adult; Aged; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle | 1994 |
Re: Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, crossover, placebo controlled study in patients with spinal cord lesion.
Topics: Ciprofloxacin; Cross-Over Studies; Humans; Prospective Studies; Randomized Controlled Trials as Topi | 1994 |
Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion.
Topics: Adult; Aged; Alanine Transaminase; Ciprofloxacin; Double-Blind Method; Feces; Female; Follow-Up Stud | 1994 |
5 other studies available for ciprofloxacin and Spinal Cord Injuries
| Article | Year |
|---|---|
Nosocomial transmission of highly resistant microorganisms on a spinal cord rehabilitation ward.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistan | 2009 |
Bacteriuria with Escherichia coli resistant to ciprofloxacin in patients with spinal-cord injury.
Topics: Adult; Anti-Infective Agents; Bacteriuria; Case-Control Studies; Ciprofloxacin; Cross Infection; Dis | 1998 |
Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Humans; Male; M | 1999 |
Antibiotic-induced release of endotoxin in chronically bacteriuric patients.
Topics: Anti-Bacterial Agents; Bacteriuria; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Endotox | 1991 |
Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria.
Topics: Adult; Bacteriuria; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Sp | 1990 |